Alembic Pharmaceuticals US

Alembic Pharmaceuticals US, established in 2011, operates as a key subsidiary of the venerable Alembic Pharmaceuticals Ltd., India's oldest pharmaceutical entity founded in 1907. This operation specializes in the research, development, manufacturing, and marketing of diverse pharmaceutical products. Its core activities encompass both active pharmaceutical ingredients (APIs) and finished dosage formulations, catering to critical healthcare needs. The company leverages its deep-rooted heritage in pharmaceutical innovation to deliver high-quality medical solutions.

With a dedicated workforce of 500-1,000 employees, Alembic Pharmaceuticals US is a significant player within the pharmaceutical sector. The company's commitment to operational excellence and product quality is paramount, supporting its mission to provide advanced pharmaceutical solutions. Contributing to a global supply chain reaching over 90 countries, it is part of an entity recognized among Asia's most respected pharmaceutical companies. Meet Alembic Pharmaceuticals US's team to understand the expertise driving their product development and market strategies. Their portfolio includes a range of pharmaceutical products, focusing on specific strengths and dosage forms.

Alembic Pharmaceuticals US is strategically positioned within the healthcare and pharmaceuticals industry, focusing on delivering specialized treatments and newly launched products. Its Bridgewater, New Jersey location serves as its operational hub. The company's revenue stands at $19.2M, reflecting its market presence and operational scale. By adhering to stringent quality standards and fostering continuous innovation, Alembic Pharmaceuticals US aims to enhance patient outcomes and solidify its reputation as a reliable provider of essential medicines in the competitive global pharmaceutical landscape.